← Back to Search

Exercise for Multiple Sclerosis (FIRMS Trial)

N/A
Waitlist Available
Led By Jacob J Sosnoff, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

FIRMS Trial Summary

This study looks to see the effects of a home based exercise program on falls in people with MS.

Eligible Conditions
  • Multiple Sclerosis

FIRMS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accidental Falls
Secondary outcome measures
Accidental Falls

FIRMS Trial Design

2Treatment groups
Experimental Treatment
Group I: ExerciseExperimental Treatment1 Intervention
In the second phase,participants will partake in an exercise course relating to gait, balance, and falls.
Group II: EducationExperimental Treatment1 Intervention
In the second phase, participants will partake in an instructional class relating to gait, balance, and falls.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
189 Previous Clinical Trials
37,285 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
585 Patients Enrolled for Multiple Sclerosis
Jacob J Sosnoff, PhDPrincipal InvestigatorMotor Control Lab, University of Illinois
1 Previous Clinical Trials
29 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
29 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Fall Risk Reduction in Multiple Sclerosis (FIRMS)
2014. "Fall Risk Reduction in Multiple Sclerosis (FIRMS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02314585.
All > Primary Progressive Multiple Sclerosis
~10 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top